FDA: Mixing Migraine, Depression Meds Risky
Posted on: Wednesday, 19 July 2006, 18:00 CDT
WASHINGTON - People taking migraine drugs together with some antidepressants are at risk of a life-threatening condition, health officials warned Wednesday.
Serotonin syndrome can occur when migraine headache drugs called triptans are taken with antidepressants known as selective serotonin/norepinephrine reuptake inhibitors, or SSRIs and SNRIs. The syndrome occurs when the body has too much of the nervous system chemical serotonin.
Patients taking the drug combination can experience restlessness, hallucinations, loss of coordination, fast heart beat, rapid changes in blood pressure, increased body temperature, overactive reflexes, nausea, vomiting and diarrhea, the FDA said.
Commonly prescribed SSRIs include Prozac, Zoloft, Paxil and Lexapro. SNRIs include Cymbalta and Effexor. Triptans include Amerge, Axert, Imitrex and Zomig.
The FDA asked the manufacturers of all three types of drugs to update their prescribing information to warn of the potential risk of serotonin syndrome.
Patients taking a triptan with either an SSRI or SNRI should talk to a doctor before stopping their medications, the FDA said.
---
On the Net:
FDA health advisory: http://www.fda.gov/cder/drug/advisory/SSRI-SS200607.htm
Source: Associated Press/AP Online
Related Articles
- FDA Accepts Addrenex's New Drug Application for CloniBID
- Datascope Receives FDA Clearance to Include Depth-of-Anesthesia Monitoring in the Spectrum(R) OR Monitor
- US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
- FDA Says Impax Parkinson's Drug Not Approvable
- Nektar Announces That U.S. FDA Has Granted Orphan Drug Designation to the First Amphotericin B Inhalation Powder to Prevent Pulmonary Fungal Infections in Immunosuppressed Patients
- FDA Strengthens Warning on Drug Paxil
- Life in Open Prisons 'Leads to Drug Taking'
- FDA Approves New Diabetes Drug
- FDA Grants Encysive Orphan Drug Designation For Thelin
- FDA Backs Anti-Nausea Drug for Some
User Comments (0)

RSS Feeds